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INTRODUCTION 
Critically ill neonates in newborn intensive care units require 
frequent monitoring of body functions. This monitoring includes 
sampling of blood for laboratory analysis. Blood samples are commonly 
obtained through an umbilical artery catheter. However, if an 
umbilical artery catheter is not in place, blood samples are fre-
quently obtained by heel stick due to difficulties inherent in venous 
sampling in this age group. These difficulties include the inability 
to find a suitable site for venipuncture, the fragility of the veins 
at this age, and the trauma associated with repeated sampling. 
Sirinavin et al, recommended that the method of heel stick sampling be 
used for the assay of antibiotics, such as gentamicin and kanamycin, 
when the only access is the same line through which the drug has been 
administered."'" This recommendation is based on the finding that ob-
taining blood specimens for antibiotic assay through the same intra-
venous line used for antibiotic administration may result in falsely 
elevated drug concentrations due to drug adhesion to the plastic 
tubing,"'" or incomplete flushing of the line after drug administration. 
Finally, vigorous flushing of the tubing with several milliliters of 
fluid before sampling may cause rupture and/or collapse of the blood 
vessel in young children. 
The heel stick sampling method assumes that capillary blood drug 
concentrations are the same as venous or arterial blood drug concentra 
tions on which most drug concentration-effect/side effect relationship 
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are based. This correlation has been proven for some laboratory para-
meters in the neonate. Segall et al, found a highly significant cor-
relation (r = 0.76, p < 0.001) between venous and heel stick capillary 
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serum ferritin concentrations in 58 healthy term infants. Kama and 
Poland studied arterial and digital capillary blood P02, PC0?, and pH 
in 33 critically ill newborn infants. A statistically significant 
correlation between the two sampling methods was found for all three 
parameters measured (P02: r = 0.92, p < 0.05; PC07: r = 0.84, 
p < 0.05; pH: r = 0.94, p < 0.05).3' 
Other monitoring parameters do not share this good correlation 
between capillary and venous or arterial blood. Rivera and Rudolph 
found a statistically significant difference (p < 0.05) between 
venous and heel stick capillary hematocrit and hemoglobin in 44 low 
birth weight and term infants, even at eight to ten postnatal weeks of 
age.^ Sluggish peripheral circulation or immature autonomic control 
of the peripheral microcirculation during the neonatal period are 
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proposed mechanisms for this difference. 
Whether free flowing capillary blood antibiotic concentrations 
correlate well with those obtained when the foot is manipulated during 
collection of the blood sample remains unanswered. Presumably, 
vigorous manipulation such as application of pressure and/or flexion 
to stimulate blood flow might dilute the blood with interstitial 
fluids. This could result in falsely lowered antibiotic concentrations. 
Such falsely lowered concentrations may lead to inappropriate dosage 
increases possibly resulting in toxicity. 
OBJECTIVE 
The objective of this study was to determine the relationship 
between gentamicin serum concentrations determined from arterial and 
heel stick capillary blood with and without manipulation of the foot. 
MATERIALS AND METHODS 
Subj ects 
Ten subjects who were patients in the University of Utah Hospital 
Newborn Intensive Care Unit were admitted to the study after informed 
consent was obtained from the parents. This study was previously ap-
proved by the University of Utah Institutional Review Board. 
All patients had stable renal and hepatic function, an umbilical 
artery catheter in place, and were receiving gentamicin for suspected 
or proven bacterial infection. Patient characteristics are listed in 
Table 1. There were five females and five males, with an average age 
of 5.7 days (range 2 to 24 days), and an average estimated gestational 
age of 31 weeks (range 26 to 38 weeks). 
Antibiotic Concentrations 
Arterial and capillary blood samples were obtained one hour after 
completion of a gentamicin infusion. Since the umbilical artery 
catheter was used for both drug administration and arterial sampling, 
it was flushed with 2 ml of normal saline solution after the gentamicin 
infusion ended, and 3 ml of blood was withdrawn prior to sampling. 
Blood samples (0.6 ml from each site) were obtained no sooner than 
after the third dose of gentamicin given. 
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Heel Stick Determinations 
Heel stick sampling was performed by either phlebotomists or 
Newborn Intensive Care Unit nurses trained in this method of sampling. 
The method of obtaining the heel stick was observed by the same in-
vestigator (RAM) each time in order to assure consistent and proper 
sampling, and to place the patient in one of the following groups: 




The blood samples were centrifuged and the serum frozen at -20°C 
immediately after being obtained. All samples were analyzed within 
24 hours at the University of Utah Hospital Clinical Toxicology 
Laboratory using the TDX fluorescence immunoassay. The sensitivity 
of the assay for serum was 0.16 mcg/ml. The coefficient of variation 
for both between-run and within-run was less than 3 percent. 
Fluorescence polarization provides a direct measure of bound and 
free tracer in a competitive binding immunoassay.^ When the tracer is 
bound to the antibody, the complex is highly polarized upon emission 
after linearly polarized light is used to excite the tracer. Conversely, 
when the tracer is free, the emitted light is depolarized. Thus, the 
greater the concentration of the analyte, the larger the fraction of 
tracer that is unbound, and the resultant emitted light is less 
polarized.^ The sensitivity of the fluorescence polarization immuno-
assay allows high dilutions of sample to be made, thereby minimizing 
interferences from protein matrix effects, lipemic samples, and those 
specimens with abnormally high hemolysis.^ 
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Data Analysis 
The null hypothesis for this study was that there is no difference 
between capillary and arterial serum gentamicin concentrations. The 
Student's t-test was used for statistical analysis for the difference 
between mean arterial and heel stick capillary serum gentamicin concen-
trations (a = 0.05). If a statistically significant difference was 
found, the degree of correlation between arterial and capillary concen-
trations was determined using the least square analysis of the concomi-
tantly obtained concentrations from the two sites. The resultant 
correlation coefficient (r) would represent the degree of correlation, 
and the significance limits for this value would then be determined 
(a = 0.05).^ These analyses were then performed separately for the 
two study groups to test the effect of heel manipulation. 
RESULTS 
The results of the arterial and capillary peak gentamicin serum 
concentrations are listed in Table 2. The average difference be-
tween these concentrations was 0.81 mcg/ml (range -0.4 to 3.2 mcg/ml). 
No statistically significant difference between mean arterial and mean 
capillary serum gentamicin concentrations was found (6.31 ± 1.61 mcg/ml 
vs 5.6 ± 1.10 mcg/ml, respectively; p > 0.05). There was also no 
significant difference between the umbilical artery catheter and heel 
stick serum gentamicin concentrations in the capillary/free flowing or 
the capillary/manipulated heel stick groups (p > 0.05). 
DISCUSSION AND CONCLUSIONS 
Peak gentamicin serum concentrations obtained from umbilical 
artery catheter and heel stick blood samples appear to be similar. 
Manipulation of the heel while obtaining capillary blood appears to 
have no effect on the resultant peak gentamicin concentration, as there 
was no significant difference (p > 0.05) between umbilical artery 
catheter and heel stick concentrations in either the capillary/free 
flowing or capillary/manipulated heel stick groups. 
Although no statistically significant difference (p > 0.05) was 
found between mean umbilical artery catheter and mean heel stick peak 
gentamicin serum concentrations for the entire patient group, the dif-
ference in these concentrations in patients weighing less than 1,000 
Gm (Patient 1: 2.7 mcg/ml; Patient 6: 3.2 mcg/ml) may be clinically 
significant, as inappropriate dosage adjustments leading to toxicity 
or suboptimal therapy could have been made. The reason for this dif-
ference in these two patients is unknown. Possibly, the distribution 
of gentamicin is impaired in critically ill neonates weighing less 
than 1,000 Gm. Further studies are needed to elucidate the actual 
mechanism. 
We conclude that in the eight patients weighing more than 1,000 
Gm there was agreement between umbilical artery catheter and heel 
stick peak gentamicin serum concentrations. There was also no signifi-
cant difference (p > 0.05) in umbilical artery catheter and heel stick 
peak gentamicin serum concentrations in the capillary/free flowing and 
manipulated heel stick study groups, indicating that manipulation of 
the heel to stimulate blood flow does not result in lower gentamicin 
concentrations. We therefore recommend that heel stick sampling for 
gentamicin concentration determination is an appropriate alternative to 
arterial sampling in critically ill neonates weighing more than 1,000 
Gm. 






























































Gram Negative Sepsis 
Rule Out Sepsis 
Rule Out Sepsis and 
Pneumonia 
Rule Out Sepsis and 
Pneumonia 
Croup B Streptococcus 
Sepsis 
Rule Out Sepsis 
Group B Streptococcus 
Sepsis 
Pneumonia 
Rule Out Sepsis 
Rule Out Sepsis 
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TABLE 2. Capillary and Arterial Peak Gentamicin Serum 
Concentrations/Type of Heel Stick 
Peak Gentamicin 
Serum Concentrations (mcg/ml) 
Patient 
Number Arterial Capillary Type of Heel Stick 
1 6.8 4.1 ' Free Flowing 
2 5.1 5 . 1 Manipulated 
3 6.8 6.3 Manipulated 
4 6.9 6.9 Free Flowing 
5 4.9 4.8 Manipulated 
6 10.3 7.1 Manipulated 
7 5.3 4.9 Free Flowing 
8 5.1 4.4 Free Flowing 
9 6.4 6.8 Manipulated 
10 5.5 5.6 Free Flowing 




DETERMINATION OF CORRELATION BETWEEN ARTERIAL AND 
CAPILLARY SERUM GENTAMICIN CONCENTRATIONS 
Date 
Consent Form 
Your child is suspected of having an infection for which he or she 
is receiving an antibiotic named gentamicin. Part of the routine care 
carried out with this treatment is to obtain a small blood sample to 
measure the amount of antibiotic present. This allows the physicians 
to determine if the antibiotic dosage is correct. In your child, the 
blood sample will be collected through a small plastic tube which has 
been temporarily placed in an artery. If a child did not have this 
tube in place, the blood would be obtained by piercing the skin of the 
heel of the foot (heel stick) which causes a small amount of blood to 
flow. 
Some controversy exists as to whether the concentration of anti-
biotic in a blood sample obtained from a heel stick is the same as 
that obtained through an artery. It is the purpose of this study, in 
which your child is invited to participate, to determine if the anti-
biotic levels obtained with the two different methods are the same. 
As the more common method of obtaining blood samples in newborn in-
fants is through a heel stick, this is an important question to answer. 
If your child is enrolled in this study (10 patients will be 
studied) a blood sample will be obtained through the artery tube (as 
ordered by the physician) and at the same time, an extra sample (0.6 
ml or about 1/10 teaspoonful) will be obtained by heel stick. The 
only risks involved are the small chance of infection and mild dis-
comfort at the heel stick site. Although there are no direct benefits 
to your child, other babies will benefit from the new knowledge 
generated. There will be no cost to you to perform this extra test. 
If you have any questions during the study, you may contact Dr. 
John Bosso (581-7545) or Dr. Cary Chan (581-7052). In the event you 
sustain physical injury resulting from the research project in which 
you are participating, the University of Utah will provide you, with-
out charge, emergency and temporary medical treatment not otherwise 
covered by insurance. Furthermore, if your injuries are caused by 
negligent acts or omissions of University employees acting in the 
course and scope of their employment, the University may be liable, 
subject to limitations prescribed by law, for additional medical costs 
and other damages you sustain. If you believe that you have suffered 
a physical injury as a result of participating in this research pro-
gram, please contact the Office of Research Administration, phone 
number 581-6903. 
Participation in this study is voluntary. I acknowledge that I 
have had a fair opportunity to ask questions about the above pro-
cedures. I understand that I am free to withdraw my consent and to 
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discontinue participation in the project at any time without prejudice. 
I agree that data from these experiments may be used for medical and 
scientific purpose, including publications, with the understanding that 
my identity will not be revealed unless I expressly consent thereto. 
Parent's 
Patient Name: Signature_ 
Witness: 
Responsible Investigator's Signature: 
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Poison Control Center 48 hours 
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Director of Pharmacy, Masonic Home & Hospital, Wallingford, CT. 
August 1978 - June 1981. Responsible for the total drug usage in 
this JCAH-accredited, 440-bed geriatric institution. 
Staff Pharmacist, Masonic Home & Hospital, Wallingford, CT. 
January 1978 - July 1978 
Staff Pharmacist, Lake Drug Co., Waterbury, CT. 
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TEACHING EXPERIENCE 
Didactic lectures to baccalaureate pharmacy students and first 
year Pharm.D. candidates. 
Preceptor for baccalaureate pharmacy students and first year 
Pharm.D. candidates on clinical rotations. 
Lectures 
"Glaucoma" Presented to fourth year undergraduate pharmacy 
students in Diseases and Drug Therapy, May 1983. 
"Seizure Disorders" Presented to first year Pharm.D. candidates 
in Advanced Pharmacotherapeuties, March 1983. 
"Seizure Disorders" Presented to fourth year undergraduate 
pharmacy students in Diseases and Drug Therapy, January 1983. 
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first year Pharm.D. candidates in Advanced Clinical Pharmaco-
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for the 1982-1983 academic year. Duties: Preparation of lecture 
materials, information source for students, proctoring and grading 
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Preparation of an oncology learning manual for use in Advanced 
Pharmacotherapeutics course for first year Pharm.D. candidates, 
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RESEARCH 
Correlation Between Capillary and Arterial Serum Gentamicin 
Concentrations in Neonates. John A. Bosso, Pharm.D., Gary M. Chan, 
M.D., John M. Matsen, M.D., Robert A. Mead, B.S. Completed May 
1983 
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"Gerovital (GH-3) Reviewed" Presented to physicians and staff, 
Geriatric Evaluation and Treatment Unit, Veterans Administration 
Medical Center, Salt Lake City, UT, June 1982. 
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"Urinary Incontinence in the Elderly" Inservice presented to 
nursing staff, Hill Haven Convalescent Center, Salt Lake City 
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medical students, University of Utah Hospital, Salt Lake City, 
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"Pharmacology of Antidepressant Agents" Presented to graduate 
student nurses, University of Utah College of Nursing, Salt Lake 
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* 
"Pharmacology of Antianxiety and Antipsychotic Agents" Presented 
to graduate student nurses, University of Utah College of Nursing, 
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"Geriatric Pharmacology" Lecture series presented biannually to 
newly hired and other interested nurses, Masonic Home & Hospital, 
Wallingford, CT, 1979-1981. 
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Mead RA: Sucralfate: the latest in the treatment of duodenal 
ulcer disease. Drugs in Patient Care, University of Utah Hospital, 
Department of Pharmacy Services. 5(-l):3, 1982. 
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COMMUNITY SERVICES 
"Medication in the Elderly" Presented at the Senior Citizen Health 
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"Poison Prevention in the Home" Presented to the Methodist 
Women's Group, Christ United Methodist Church, Salt Lake City, 
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Health Screening Center. Functioned as consultant, drug infor-
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for the elderly, Salt Lake City, UT, August-September 1981. 
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